CORC

在结果中检索

CORC

浏览/检索结果: 共21条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract 期刊论文
CANCER COMMUNICATIONS, 2022
作者:  Wu, Huanwen;  Yu, Zicheng;  Liu, Yueping;  Guo, Lei;  Teng, Lianghong
收藏  |  浏览/下载：23/0  |  提交时间：2022/12/22
Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:  Tao, Zhonghua;  Liu, Jianxia;  Li, Ting;  Xu, Hong;  Chen, Kai
收藏  |  浏览/下载：33/0  |  提交时间：2022/01/10
PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文
LUNG CANCER, 2020, 卷号: 142
作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun
收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation 期刊论文
ONCOGENE, 2020, 卷号: 39
作者:  Jin, Ying;  Bao, Hua;  Le, Xiuning;  Fan, Xiaojun;  Tang, Ming
收藏  |  浏览/下载：26/0  |  提交时间：2020/11/26
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li, Qiao;  Guan, Xiuwen;  Chen, Shanshan;  Yi, Zongbi;  Lan, Bo
收藏  |  浏览/下载：15/0  |  提交时间：2020/07/01
Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure-activity relationship, crystal structural characterization and and in vivo study 期刊论文
ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 2, 页码: 351-368
作者:  Wei, Peng;  Liu, Bo;  Wang, Ruifeng;  Gao, Yinglei;  Li, Lanlan
收藏  |  浏览/下载：103/0  |  提交时间：2020/07/01
discoveryofaseriesofdimethoxybenzenefgfrinhibitorswith5hpyrrolo23bpyrazinescaffoldstructureactivityrelationshipcrystalstructuralcharacterizationandinvivostudy 期刊论文
actapharmaceuticasinicab, 2019, 卷号: 9, 期号: 2, 页码: 351
作者:  Wei Peng;  Liu Bo;  Wang Ruifeng;  Gao Yinglei;  Li Lanlan
收藏  |  浏览/下载：30/0  |  提交时间：2020/07/01
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2018, 卷号: 17, 期号: 4, 页码: 751-762
作者:  Ai, Jing;  Chen, Yi;  Peng, Xia;  Ji, Yinchun;  Xi, Yong
收藏  |  浏览/下载：50/0  |  提交时间：2019/01/08
[The concomitant gene alterations impact the therapeutic efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutation]. 期刊论文
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2018, 卷号: 41, 期号: 10
作者:  Li J M;  Hu J;  Bai C X;  Zhang Y;  Xu X B
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib 期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 11, 页码: 2594-2604
作者:  Liu, Shengwu;  Hai, Josephine;  Wang, Xiaoen;  Quinn, Max M.;  Gao, Peng
收藏  |  浏览/下载：81/0  |  提交时间：2019/04/28

©版权所有 ©2017 CSpace - Powered by CSpace